Skip to main content

Advertisement

SpringerLink
Log in

Italian Guidelines for the Diagnosis and Infectious Disease Management of Osteomyelitis and Prosthetic Joint Infections in Adults

  • Review
  • Published:
Infection Aims and scope Submit manuscript

Abstract

Bone and joint infections are recognized as difficult-to-treat infections that result in significant morbidity and mortality among patients and increased healthcare costs. This article presents the recommendations for the diagnosis and management of osteomyelitis and prosthetic joint infections in adults developed by Bone and Joint Infections Committee for the Italian Society of Infectious and Tropical Diseases. It contains data published through to November 2007. An evidence-based scoring system that is used by the Infectious Diseases Society of America was applied to treatment recommendations.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Kish MA: Guide to development of practice guidelines. Clin Infect Dis 2001; 32: 851–854.

    CAS  PubMed  Google Scholar 

  2. Masterson EL, Masri BA, Duncan CP: Treatment of infection at the site of total hip replacement. Instr Course Lect 1998; 47: 297–306.

    CAS  PubMed  Google Scholar 

  3. Sculco TP: The economic impact of infected total joint arthroplasty. Instr Course Lect 1993; 42: 349–351.

    CAS  PubMed  Google Scholar 

  4. Hanssen AD, Rand JA: Evaluation and treatment of infection at the site of a total hip or knee arthroplasty. Instr Course Lect 1999; 48: 111–122.

    CAS  PubMed  Google Scholar 

  5. Cofield RH: Uncemented total shoulder arthroplasty: a review. Clin Orthop Relat Res 1994; 307: 86–93.

    PubMed  Google Scholar 

  6. Wilson MG, Kelley K, Thornhill TS: Infection as a complication of total knee-replacement arthroplasty: risk factors and treatment in sixty-seven cases. J Bone Joint Surg Am 1990; 72: 878–883.

    CAS  PubMed  Google Scholar 

  7. Poss R, Thornhill TS, Ewald FC, Thomas WH, Batte NJ, Sledge CB: Factors influencing the incidence and outcome of infection following total joint arthroplasty. Clin Orthop Relat Res 1984; 182: 117–126.

    PubMed  Google Scholar 

  8. Salvati EA, Robinson RP, Zeno SM, Koslin BL, Brause BD, Wilson PD Jr: Infection rates after 3,175 total hip and total knee replacements performed with and without a horizontal unidirectional filtered air-flow system. J Bone Joint Surg Am 1982; 64: 525–535.

    CAS  PubMed  Google Scholar 

  9. Berbari EF, Hanssen AD, Duffy MC, Steckelberg JM, Ilstrup DM, Harmsen WS, Osmon DR: Risk factors for prosthetic joint infection: case-control study. Clin Infect Dis 1998; 27: 1247–1254.

    CAS  PubMed  Google Scholar 

  10. Hoekman P, van de Perre P, Nelissen J, Kwisanga B, Bogaerts J, Kanyangabo F: Increased frequency of infection after open reduction of fractures in patients who are seropositive for human immunodeficiency virus. J Bone Joint Surg Am 1991; 73: 675–679.

    CAS  PubMed  Google Scholar 

  11. Harrison WJ, Lewis CP, Lavy CB: Wound healing after implant surgery in HIV-positive patients. J Bone Joint Surg Br 2002; 84: 802–806.

    CAS  PubMed  Google Scholar 

  12. Zimmerli W: Prosthetic device infections. In: Root RK, Waldvogel FA, Corey L, Stamm WE (eds): Clinical infectious diseases: a practical approach. Oxford: Oxford University Press, 1999, pp 801–808.

    Google Scholar 

  13. Widmer AF: New developments in diagnosis and treatment of infection in orthopedic implants. Clin Infect Dis 2001; 33(Suppl 2): S94–S106.

    PubMed  Google Scholar 

  14. Zimmerli W, Trampuz A, Ochsner PE: Prosthetic-joint infections. N Engl J Med 2004; 351: 1645–1654.

    CAS  PubMed  Google Scholar 

  15. Moran E, Masters S, Berendt AR, McLardy-Smith P, Byren I, Atkins BL: Guiding empirical antibiotic therapy in orthopaedics: the microbiology of prosthetic joint infection managed by debridement, irrigation and prosthesis retention. J Infect 2007; 55: 1–7.

    CAS  PubMed  Google Scholar 

  16. Berbari EF, Marculescu C, Sia I, Lahr BD, Hanssen AD, Steckelberg JM, Gullerud R, Osmon DR: Culture-negative prosthetic joint infection. Clin Infect Dis 2007; 45: 1113–1119.

    PubMed  Google Scholar 

  17. Phelan DM, Osmon DR, Keating MR, Hanssen AD: Delayed reimplantation arthroplasty for candidal prosthetic joint infection: a report of 4 cases and review of the literature. Clin Infect Dis 2002; 34: 930–938.

    PubMed  Google Scholar 

  18. Weil Y, Mattan Y, Liebergall M, Rahav G: Brucella prosthetic joint infection: a report of 3 cases and a review of the literature. Clin Infect Dis 2003; 36: e81–e86.

    CAS  PubMed  Google Scholar 

  19. Tokumoto JI, Follansbee SE, Jacobs RA: Prosthetic joint infection due to Mycobacterium tuberculosis: report of three cases. Clin Infect Dis 1995; 21: 134–136.

    CAS  PubMed  Google Scholar 

  20. Eid AJ, Berbari EF, Sia IG, Wengenack NL, Osmon DR, Razonable RR: Prosthetic joint infection due to rapidly growing mycobacteria: report of 8 cases and review of the literature. Clin Infect Dis 2007; 45: 687–694.

    PubMed  Google Scholar 

  21. Marculescu CE, Berbari EF, Cockerill FR 3rd, Osmon DR: Fungi, mycobacteria, zoonotic and other organisms in prosthetic joint infection. Clin Orthop Relat Res 2006; 451: 64–72.

    PubMed  Google Scholar 

  22. Choudhry RR, Rice RP, Triffitt PD, Harper WM, Gregg PJ: Plasma viscosity and C-reactive protein after total hip and knee arthroplasty. J Bone Joint Surg Br 1992; 74: 523–524.

    CAS  PubMed  Google Scholar 

  23. Visser M, Bouter LM, McQuillan GM, Wener MH, Harris TB: Elevated C-reactive protein levels in overweight and obese adults. JAMA 1999; 282: 2131–2135.

    CAS  PubMed  Google Scholar 

  24. Bernard L, Lübbeke A, Stern R, Bru JP, Feron JM, Peyramond D, Denormandie P, Arvieux C, Chirouze C, Perronne C, Hoffmeyer P: Value of preoperative investigations in diagnosing prosthetic joint infection: retrospective cohort study and literature review. Scand J Infect Dis 2004; 36: 410–416.

    PubMed  Google Scholar 

  25. Sanzén L, Carlsson AS: The diagnostic value of C-reactive protein in infected total hip arthroplasties. J Bone Joint Surg Br 1989; 71: 638–641.

    PubMed  Google Scholar 

  26. Spangehl MJ, Masri BA, O’Connell JX, Duncan CP: Prospective analysis of preoperative and intraoperative investigations for the diagnosis of infection at the sites of two hundred and two revision total hip arthroplasties. J Bone Joint Surg Am 1999; 81: 672–683.

    CAS  PubMed  Google Scholar 

  27. Shih LY, Wu JJ, Yang DJ: Erythrocyte sedimentation rate and C-reactive protein values in patients with total hip arthroplasty. Clin Orthop Relat Res 1987; 225: 238–246.

    PubMed  Google Scholar 

  28. Bottner F, Wegner A, Winkelmann W, Becker K, Erren M, Götze C: Interleukin-6, procalcitonin and TNF-alpha: markers of periprosthetic infection following total joint replacement. J Bone Joint Surg Br 2007; 89: 94–99.

    CAS  PubMed  Google Scholar 

  29. Trampuz A, Hanssen AD, Osmon DR, Mandrekar J, Steckelberg JM, Patel R: Synovial fluid leukocyte count and differential for the diagnosis of prosthetic knee infection. Am J Med 2004; 117: 556–562.

    PubMed  Google Scholar 

  30. Duff GP, Lachiewicz PF, Kelley SS: Aspiration of the knee joint before revision arthroplasty. Clin Orthop Relat Res 1996; 331: 132–139.

    PubMed  Google Scholar 

  31. Lachiewicz PF, Rogers GD, Thomason HC: Aspiration of the hip joint before revision total hip arthroplasty: clinical and laboratory factors influencing attainment of a positive culture. J Bone Joint Surg Am 1996; 78: 749–754.

    CAS  PubMed  Google Scholar 

  32. Atkins BL, Athanasou N, Deeks JJ, Crook DW, Simpson H, Peto TE, McLardy-Smith P, Berendt AR: Prospective evaluation of criteria for microbiological diagnosis of prosthetic-joint infection at revision arthroplasty: The OSIRIS Collaborative Study Group. J Clin Microbiol 1998; 36: 2932–2939.

    CAS  PubMed  Google Scholar 

  33. Trampuz A, Hanssen AD, Osmon DR, Mandrekar J, Steckelberg JM, Patel R: Advances in the laboratory diagnosis of prosthetic joint infection. Rev Med Microbiol 2003; 14: 1–14.

    Google Scholar 

  34. Zeller V, Ghorbani A, Strady C, Leonard P, Mamoudy P, Desplaces N: Propionibacterium acnes: an agent of prosthetic joint infection and colonization. J Infect 2007; 55: 119–124.

    PubMed  Google Scholar 

  35. Trampuz A, Piper KE, Jacobson MJ, Hanssen AD, Unni KK, Osmon DR, Mandrekar JN, Cockerill FR, Steckelberg JM, Greenleaf JF, Patel R: Sonication of removed hip and knee prostheses for diagnosis of infection. N Engl J Med 2007; 357: 654–663.

    CAS  PubMed  Google Scholar 

  36. Athanasou NA, Pandey R, de Steiger R, Crook D, Smith PM: Diagnosis of infection by frozen section during revision arthroplasty. J Bone Joint Surg Br 1995; 77: 28–33.

    CAS  PubMed  Google Scholar 

  37. Feldman DS, Lonner JH, Desai P, Zuckerman JD: The role of intraoperative frozen sections in revision total joint arthroplasty. J Bone Joint Surg Am 1995; 77: 1807–1813.

    CAS  PubMed  Google Scholar 

  38. Levine MJ, Mariani BA, Tuan RS, Booth RE Jr: Molecular genetic diagnosis of infected total joint arthroplasty. J Arthroplasty 1995; 10: 93–94.

    CAS  PubMed  Google Scholar 

  39. Hoeffel DP, Hinrichs SH, Garvin KL: Molecular diagnostics for the detection of musculoskeletal infection. Clin Orthop Relat Res 1999; 360: 37–46.

    PubMed  Google Scholar 

  40. Cuckler JM, Star AM, Alavi A, Noto RB: Diagnosis and management of the infected total joint arthroplasty. Orthop Clin North Am 1991; 22: 523–530.

    CAS  PubMed  Google Scholar 

  41. Tigges S, Stiles RG, Roberson JR: Appearance of septic hip prostheses on plain radiographs. AJR Am J Roentgenol 1994; 163: 377–380.

    CAS  PubMed  Google Scholar 

  42. Goergen TG, Dalinka MK, Alazraki N, Berquist TH, Daffner RH, DeSmet AA, el-Khoury GY, Keats TE, Manaster BJ, Newberg A, Pavlov H, Haralson RH 3rd, McCabe JB, Sartoris D: Evaluation of the patient with painful hip or knee arthroplasty. American College of Radiology. ACR appropriateness criteria. Radiology 2000; 215(Suppl): 295–298.

    PubMed  Google Scholar 

  43. Cyteval C, Hamm V, Sarrabère MP, Lopez FM, Maury P, Taourel P: Painful infection at the site of hip prosthesis: CT imaging. Radiology 2002; 224: 477–483.

    PubMed  Google Scholar 

  44. Smith SL, Wastie ML, Forster I: Radionuclide bone scintigraphy in the detection of significant complications after total knee joint replacement. Clin Radiol 2001; 56: 221–224.

    CAS  PubMed  Google Scholar 

  45. Palestro CJ, Torres MA: Radionuclide imaging in orthopedic infections. Semin Nucl Med 1997; 27: 334–345.

    CAS  PubMed  Google Scholar 

  46. Spangehl MJ, Younger AS, Masri BA, Duncan CP: Diagnosis of infection following total hip arthroplasty. Instr Course Lect 1998; 47: 285–295.

    CAS  PubMed  Google Scholar 

  47. Kantor SG, Schneider R, Insall JN, Becker MW: Radionuclide imaging of asymptomatic versus symptomatic total knee arthroplasties. Clin Orthop Relat Res 1990; 260: 118–123.

    PubMed  Google Scholar 

  48. Love C, Tomas MB, Marwin SE, Pugliese PV, Palestro CJ: Role of nuclear medicine in diagnosis of the infected joint replacement. Radiographics 2001; 21: 1229–1238.

    CAS  PubMed  Google Scholar 

  49. http://www.aimn.it/pubblicazioni/LG/LGP_AIMN.PDF.

  50. Prandini N, Lazzeri E, Rossi B, Erba P, Parisella MG, Signore A: Nuclear medicine imaging of bone infections. Nucl Med Commun 2006; 27: 633–644.

    PubMed  Google Scholar 

  51. Devillers A, Garin E, Polard JL, Poirier JY, Arvieux C, Girault S, Moisan A, Bourguet P: Comparison of Tc-99m-labelled antileukocyte fragment Fab’ and Tc-99 m-HMPAO leukocyte scintigraphy in the diagnosis of bone and joint infections: a prospective study. Nucl Med Commun 2000; 21: 747–753.

    CAS  PubMed  Google Scholar 

  52. Simonsen L, Buhl A, Oersnes T, Duus B: White blood cell scintigraphy for differentiation of infection and aseptic loosening: a retrospective study of 76 painful hip prostheses. Acta Orthop 2007; 78: 640–647.

    PubMed  Google Scholar 

  53. Sarda L, Cremieux AC, Lebellec Y, Meulemans A, Lebtahi R, Hayem G, Genin R, Delahaye N, Huten D, Le Guludec D: Inability of 99mTc-ciprofloxacin scintigraphy to discriminate between septic and sterile osteoarticular diseases. J Nucl Med 2003; 44: 920–926.

    PubMed  Google Scholar 

  54. Sarda L, Saleh-Mghir A, Peker C, Meulemans A, Cremieux AC, Le Guludec D: Evaluation of (99m)Tc-ciprofloxacin scintigraphy in a rabbit model of Staphylococcus aureus prosthetic joint infection. J Nucl Med 2002; 43: 239–245.

    PubMed  Google Scholar 

  55. de Winter F, van de Wiele C, Vogelaers D, de Smet K, Verdonk R, Dierckx RA: Fluorine-18 fluorodeoxyglucose-position emission tomography: a highly accurate imaging modality for the diagnosis of chronic musculoskeletal infections. J Bone Joint Surg Am 2001; 83A: 651–660.

    Google Scholar 

  56. Delank KS, Schmidt M, Michael JW, Dietlein M, Schicha H, Eysel P: The implications of 18F-FDG PET for the diagnosis of endoprosthetic loosening and infection in hip and knee arthroplasty: results from a prospective, blinded study. BMC Musculoskelet Disord 2006; 7: 20–29.

    PubMed  Google Scholar 

  57. Love C, Pugliese PV, Afriyie MO, Tomas MB, Marwin SE, Palestro CJ: Utility of F-18 FDG imaging for diagnosing the infected joint replacement. Clin Positron Imaging 2000; 3: 159.

    PubMed  Google Scholar 

  58. Bleeker-Rovers CP, Vos FJ, Corstens FH, Oyen WJ: Imaging of infectious diseases using [(18)F]fluorodeoxyglucose positron emission tomography. Q J Nucl Med Mol Imaging 2008; 52: 17–29.

    CAS  PubMed  Google Scholar 

  59. Costerton JW, Stewart PS, Greenberg EP: Bacterial biofilms: a commoncause of persistent infections. Science 1999; 284: 1318–1322.

    CAS  PubMed  Google Scholar 

  60. Zimmerli W, Widmer AF, Blatter M, Frei R, Ochsner PE: Role of rifampin for treatment of orthopedic implant-related staphylococcal infections: a randomized controlled trial. Foreign-Body Infection (FBI) Study Group. JAMA 1998; 279: 1537–1541.

    CAS  PubMed  Google Scholar 

  61. Drancourt M, Stein A, Argenson JN, Zannier A, Curvale G, Raoult D: Oral rifampin plus ofloxacin for treatment of Staphylococcus-infected orthopedic implants. Antimicrob Agents Chemother 1993; 37: 1214–1218.

    CAS  PubMed  Google Scholar 

  62. Widmer AF, Frei R, Rajacic Z, Zimmerli W: Correlation between in vivo and in vitro efficacy of antimicrobial agents against foreign body infections. J Infect Dis 1990; 162: 96–102.

    CAS  PubMed  Google Scholar 

  63. Perlroth J, Kuo M, Tan J, Bayer AS, Miller LG: Adjunctive use of rifampin for the treatment of Staphylococcus aureus infections: a systematic review of the literature. Arch Intern Med 2008; 168: 805–819.

    CAS  PubMed  Google Scholar 

  64. Mandell GL: The antimicrobial activity of rifampin: emphasis on the relation to phagocytes. Rev Infect Dis 1983; 5: S463–S467.

    CAS  PubMed  Google Scholar 

  65. Trampuz A, Widmer AF: Infections associated with orthopedic implants. Curr Opin Infect Dis 2006; 19: 349–356.

    CAS  PubMed  Google Scholar 

  66. Stengel D, Bauwens K, Sehouli J, Ekkernkamp A, Porzsolt F: Systematic review and meta-analysis of antibiotic therapy for bone and joint infections. Lancet Infect Dis 2001; 1: 175–188.

    CAS  PubMed  Google Scholar 

  67. Berdal JE, Skråmm I, Mowinckel P, Gulbrandsen P, Bjørnholt JV: Use of rifampicin and ciprofloxacin combination therapy after surgical debridement in the treatment of early manifestation prosthetic joint infections. Clin Microbiol Infect 2005; 11: 843–845.

    CAS  PubMed  Google Scholar 

  68. Esposito S, Leone S, Noviello S, Ianniello F, Fiore M, Russo M, Foti G, Carpentieri MS, Cellesi C, Zanelli G, Cellini A, Girmenia C, De Lalla F, Maiello A, Maio P, Marranconi F, Sabbatani S, Pantaleoni M, Ghinelli F, Soranzo ML, Vigano P, Re T, Viale P, Scudeller L, Scaglione F, Vullo V: Outpatient parenteral antibiotic therapy for bone and joint infections: an Italian multicenter study. J Chemother 2007; 19: 417–422.

    CAS  PubMed  Google Scholar 

  69. Greenberg RN, Newman MT, Shariaty S, Pectol RW: Ciprofloxacin, lomefloxacin, or levofloxacin as treatment for chronic osteomyelitis. Antimicrob Agents Chemother 2000; 44: 164–166.

    CAS  PubMed  Google Scholar 

  70. Frippiat F, Meunier F, Derue G: Place of newer quinolones and rifampicin in the treatment of Gram-positive bone and joint infections. J Antimicrob Chemother 2004; 54: 1158.

    CAS  PubMed  Google Scholar 

  71. Soriano A, Jurado A, Marco F, Almela M, Ortega M, Mensa J: In vitro activity of linezolid, moxifloxacin, levofloxacin, clindamycin and rifampin, alone and in combination, against Staphylococcus aureus and Staphylococcus epidermidis. Rev Esp Quimioter 2005; 18: 168–172.

    CAS  PubMed  Google Scholar 

  72. Lemmen SW, Hafner H, Klik S, Lutticken R, Zolldann D: Comparison of the bactericidal activity of moxifloxacin and levofloxacin against Staphylococcus aureus, Staphylococcus epidermidis, Escherichia coli and Klebsiella pneumoniae. Chemotherapy 2003; 49: 33–35.

    CAS  PubMed  Google Scholar 

  73. Barberan J, Carroquino G, Gonzalez F: Levofloxacin plus rifampicin treatment of staphylococcal prosthetic joint infections with prosthesis. Enferm Infecc Microbiol Clin 2004; 22(Suppl 1): 122–128.

    Google Scholar 

  74. Drancourt M, Stein A, Argenson JN, Roiron R, Groulier P, Raoult D: Oral treatment of Staphylococcus spp. infected orthopaedic implants with fusidic acid or ofloxacin in combination with rifampicin. J Antimicrob Chemother 1997; 39: 235–240.

    CAS  PubMed  Google Scholar 

  75. Stein A, Bataille JF, Drancourt M, Curvale G, Argenson JN, Groulier P, Raoult D: Ambulatory treatment of multidrug-resistant Staphylococcus-infected orthopaedic implants with high-dose oral co-trimoxazole (trimethoprim-sulfamethoxazole). Antimicrob Agents Chemother 1998; 42: 3086–3091.

    CAS  PubMed  Google Scholar 

  76. Trampuz A, Zimmerli W: New strategies for the treatment of infections associated with prosthetic joints. Curr Opin Invest Drugs 2005; 6: 185–190.

    CAS  Google Scholar 

  77. Pavoni GL, Giannella M, Falcone M, Scorzolini L, Liberatore M, Carlesimo B, Serra P, Venditti M: Conservative medical therapy of prosthetic joint infections: retrospective analysis of an 8-year experience. Clin Microbiol Infect 2004; 10: 831–837.

    CAS  PubMed  Google Scholar 

  78. Meehan AM, Osmon DR, Duffy MC, Hanssen AD, Keating MR: Outcome of penicillin-susceptible streptococcal prosthetic joint infection treated with debridement and retention of the prosthesis. Clin Infect Dis 2003; 36: 845–849.

    CAS  PubMed  Google Scholar 

  79. Bernard L, El-Hajj PB, Lotthé A, Gleizes V, Signoret F, Denormandie P, Gaillard JL, Perronne C: Outpatient parenteral antimicrobial therapy (OPAT) for the treatment of osteomyelitis: evaluation of efficacy, tolerance and cost. J Clin Pharm Ther 2001; 26: 445–451.

    CAS  PubMed  Google Scholar 

  80. Stein A, Drancourt M, Raoult D: Ambulatory management of infected orthopaedic implants. In: Waldvogel FA, Bisno AL (eds) Infections associated with indwelling medical devices. ASM Press, Washington, DC 2000, pp 211–230.

    Google Scholar 

  81. Drew RH, Perfect JR, Srinath L, Kurkimilis E, Dowzicky M, Talbot GH: Treatment of methicillin-resistant staphylococcus aureus infections with quinupristin-dalfopristin in patients intolerant of or failing prior therapy: for the synercid emergency-Use Study Group. J Antimicrob Chemother 2000; 46: 775–784.

    CAS  PubMed  Google Scholar 

  82. Rana B, Butcher I, Grigoris P, Murnaghan C, Seaton RA, Tobin CM: Linezolid penetration into osteo-articular tissues. J Antimicrob Chemother 2002; 50: 747–750.

    CAS  PubMed  Google Scholar 

  83. Kutscha-Lissberg F, Hebler U, Muhr G, Köller M: Linezolid penetration into bone and joint tissues infected with methicillin-resistant staphylococci. Antimicrob Agents Chemother 2003; 47: 3964–3966.

    CAS  PubMed  Google Scholar 

  84. Lovering AM, Zhang J, Bannister GC, Lankester BJ, Brown JH, Narendra G, MacGowan AP: Penetration of linezolid into bone, fat, muscle and haematoma of patients undergoing routine hip replacement. J Antimicrob Chemother 2002; 50: 73–77.

    CAS  PubMed  Google Scholar 

  85. Bassetti M, Vitale F, Melica G, Righi E, Di Biagio A, Molfetta L, Pipino F, Cruciani M, Bassetti D: Linezolid in the treatment of Gram-positive prosthetic joint infections. J Antimicrob Chemother 2005; 55: 387–390.

    CAS  PubMed  Google Scholar 

  86. Razonable RR, Osmon DR, Steckelberg JM: Linezolid therapy for orthopedic infections. Mayo Clin Proc 2004; 79: 1137–1144.

    CAS  PubMed  Google Scholar 

  87. Howden BP, Ward PB, Charles PG, Korman TM, Fuller A, du Cros P, Grabsch EA, Roberts SA, Robson J, Read K, Bak N, Hurley J, Johnson PD, Morris AJ, Mayall BC, Grayson ML: Treatment outcomes for serious infections caused by methicillin-resistant Staphylococcus aureus with reduced vancomycin susceptibility. Clin Infect Dis 2004; 38: 521–528.

    CAS  PubMed  Google Scholar 

  88. Rao N, Ziran BH, Hall RA, Santa ER: Successful treatment of chronic bone and joint infections with oral linezolid. Clin Orthop Relat Res 2004; 427: 67–71.

    PubMed  Google Scholar 

  89. Soriano A, Gómez J, Gómez L, Azanza JR, Pérez R, Romero F, Pons M, Bella F, Velasco M, Mensa J: Efficacy and tolerability of prolonged linezolid therapy in the treatment of orthopedic implant infections. Eur J Clin Microbiol Infect Dis 2007; 26: 353–356.

    CAS  PubMed  Google Scholar 

  90. Rao N, Hamilton CW: Efficacy and safety of linezolid for Gram-positive orthopedic infections: a prospective case series. Diagn Microbiol Infect Dis 2007; 59: 173–179.

    CAS  PubMed  Google Scholar 

  91. Rucker JC, Hamilton SR, Bardenstein D, Isada CM, Lee MS: Linezolid-associated toxic optic neuropathy. Neurology 2006; 66: 595–598.

    CAS  PubMed  Google Scholar 

  92. Gebhart BC, Barker BC, Markewitz BA: Decreased serum linezolid levels in a critically ill patient receiving concomitant linezolid and rifampin. Pharmacotherapy 2007; 27: 476–479.

    CAS  PubMed  Google Scholar 

  93. Carpenter CF, Chambers HF: Daptomycin: another novel agent for treating infections due to drug-resistant gram-positive pathogens. Clin Infect Dis 2004; 38: 994–1000.

    CAS  PubMed  Google Scholar 

  94. Antony SJ, Angelos E, Stratton CW: Clinical experience with daptomycin in patients with orthopedic-related infections. Infect Dis Clin Pract 2006; 14: 144–149.

    Google Scholar 

  95. Rao N, Regalla DM: Uncertain efficacy of daptomycin for prosthetic joint infections: a prospective case series. Clin Orthop Relat Res 2006; 451: 34–37.

    PubMed  Google Scholar 

  96. Finney MS, Crank CW, Segreti J: Use of daptomycin to treat drug resistant Gram-positive bone and joint infections. Curr Med Res Opin 2005; 21: 1923–1926.

    CAS  PubMed  Google Scholar 

  97. Tsukayama DT, Estrada R, Gustilo RB: Infection after total hip arthroplasty: a study of the treatment of one hundred and six infections. J Bone Joint Surg Am 1996; 78: 512–523.

    CAS  PubMed  Google Scholar 

  98. Segawa H, Tsukayama DT, Kyle RF, Becker DA, Gustilo RB: Infection after total knee arthroplasty: a retrospective study of the treatment of eighty-one infections. J Bone Joint Surg Am 1999; 81: 1434–1445.

    CAS  PubMed  Google Scholar 

  99. Brandt CM, Sistrunk WW, Duffy MC, Hanssen AD, Steckelberg JM, Ilstrup DM, Osmon DR: Staphylococcus aureus prosthetic joint infection treated with debridement and prosthesis retention. Clin Infect Dis 1997; 24: 914–919.

    CAS  PubMed  Google Scholar 

  100. Tattevin P, Crémieux AC, Pottier P, Huten D, Carbon C: Prosthetic joint infection: when can prosthesis salvage be considered?. Clin Infect Dis 1999; 29: 292–295.

    CAS  PubMed  Google Scholar 

  101. Barberán J, Aguilar L, Carroquino G, Giménez MJ, Sánchez B, MartÍnez D, Prieto J: Conservative treatment of staphylococcal prosthetic joint infections in elderly patients. Am J Med 2006; 119: 993.e7–993.e10.

    Google Scholar 

  102. Trebse R, Pisot V, Trampuz A: Treatment of infected retained implants. J Bone Joint Surg Br 2005; 87: 249–256.

    CAS  PubMed  Google Scholar 

  103. Fisman DN, Reilly DT, Karchmer AW, Goldie SJ: Clinical effectiveness and cost-effectiveness of 2 management strategies for infected total hip arthroplasty in the elderly. Clin Infect Dis 2001; 32: 419–430.

    CAS  PubMed  Google Scholar 

  104. Bernard L, Hoffmeyer P, Assal M, Vaudaux P, Schrenzel J, Lew D: Trends in the treatment of orthopaedic prosthetic infections. J Antimicrob Chemother 2004; 53: 127–129.

    CAS  PubMed  Google Scholar 

  105. Barberán J: Management of infections of osteoarticular prosthesis. Clin Microbiol Infect 2006; 12(Suppl 3): 93–101.

    PubMed  Google Scholar 

  106. Ure KJ, Amstutz HC, Nasser S, Schmalzried TP: Direct-exchange arthroplasty for the treatment of infection after total hip replacement: an average ten-year follow-up. J Bone Joint Surg Am 1998; 80: 961–968.

    CAS  PubMed  Google Scholar 

  107. Raut VV, Orth MS, Orth MC, Siney PD, Wroblewski BM: One stage revision arthroplasty of the hip for deep gram-negative infection. Int Orthop 1996; 20: 12–14.

    CAS  PubMed  Google Scholar 

  108. Hope PG, Kristinsson KG, Norman P, Elson RA: Deep infection of cemented total hip arthroplasties caused by coagulase-negative staphylococci. J Bone Joint Surg Br 1989; 71: 851–855.

    CAS  PubMed  Google Scholar 

  109. Raut VV, Siney PD, Wroblewski BM: One-stage revision of infected total hip replacements with discharging sinuses. J Bone Joint Surg Br 1994; 76: 721–724.

    CAS  PubMed  Google Scholar 

  110. Jackson WO, Schmalzried TP: Limited role of direct exchange arthroplasty in the treatment of infected total hip replacements. Clin Orthop Relat Res 2000; 381: 101–105.

    PubMed  Google Scholar 

  111. Zimmerli W, Ochsner PE: Management of infection associated with prosthetic joints. Infection 2003; 31: 99–108.

    CAS  PubMed  Google Scholar 

  112. Langlais F: Can we improve the results of revision arthroplasty for infected total hip replacement? J Bone Joint Surg Br 2003; 85: 637–640.

    PubMed  Google Scholar 

  113. Brandt CM, Duffy MC, Berbari EF, Hanssen AD, Steckelberg JM, Osmon DR: Staphylococcus aureus prosthetic joint infection treated with prosthesis removal and delayed reimplantation arthroplasty. Mayo Clin Proc 1999; 74: 553–558.

    CAS  PubMed  Google Scholar 

  114. Colyer RA, Capello WN: Surgical treatment of the infected hip implant: two stage reimplantation with a one month interval. Clin Orthop 1994; 298: 75–79.

    PubMed  Google Scholar 

  115. Cherney DL, Amstutz HC: Total hip replacement in the previously septic hip. J Bone Joint Surg Am 1983; 65: 1256–1265.

    CAS  PubMed  Google Scholar 

  116. Sia IG, Berbari EF, Karchmer AW: Prosthetic joint infections. Infect Dis Clin North Am 2005; 19: 885–914.

    PubMed  Google Scholar 

  117. McDonald DJ, Fitzgerald RH Jr, Ilstrup DM: Two stage reconstruction of a total hip arthroplasty because of infection. J Bone Joint Surg Am 1989; 71: 828–834.

    CAS  PubMed  Google Scholar 

  118. Mont MA, Waldman BJ, Hungerford DS: Evaluation of preoperative cultures before second-stage reimplantation of a total knee prosthesis complicated by infection: a comparison-group study. J Bone Joint Surg Am 2000; 82: 1552–1557.

    PubMed  Google Scholar 

  119. Bengston S, Knutson K, Lidgren L: Treatment of infected knee arthroplasty. Clin Orthop Relat Res 1989; 245: 173–178.

    PubMed  Google Scholar 

  120. Rand JA, Bryan RS, Chao EY: Failed total knee arthroplasty treated by arthrodesis of the knee using the Ace-Fischer apparatus. J Bone Joint Surg Am 1987; 69: 39–45.

    CAS  PubMed  Google Scholar 

  121. Damron TA, McBeath AA: Arthrodesis following failed total knee arthroplasty: comprehensive review and meta-analysis of recent literature. Orthopedics 1995; 18: 361–368.

    CAS  PubMed  Google Scholar 

  122. Kaufer H, Matthews LS: Resection arthroplasty: an alternative to arthrodesis for salvage of the infected total knee arthroplasty. Instr Course Lect 1986; 35: 283–289.

    CAS  PubMed  Google Scholar 

  123. Isiklar ZU, Landon GC, Tullos HS: Amputation after failed total knee arthroplasty. Clin Orthop Relat Res 1994; 299: 173–178.

    PubMed  Google Scholar 

  124. Sierra RJ, Trousdale RT, Pagnano MW: Above-the-knee amputation after a total knee replacement: prevalence, etiology, and functional outcome. J Bone Joint Surg Am 2003; 85A: 1000–1004.

    Google Scholar 

  125. Segreti J, Nelson JA, Trenholme GM: Prolonged suppressive antibiotic therapy for infected orthopedic prostheses. Clin Infect Dis 1998; 27: 711–713.

    CAS  PubMed  Google Scholar 

  126. Trampuz A, Zimmerli W: Antimicrobial agents in orthopaedic surgery: prophylaxis and treatment. Drugs 2006; 66: 1089–1105.

    CAS  PubMed  Google Scholar 

  127. Carlsson AS, Josefsson G, Lindberg L: Revision with gentamicinimpregnated cement for deep infections in total hip arthroplasties. J Bone Joint Surg Am 1978; 60: 1059–1064.

    CAS  PubMed  Google Scholar 

  128. Chiu FY, Chen CM, Lin CF, Lo WH: Cefuroxime-impregnated cement in primary total knee arthroplasty: a prospective, randomized study of three hundred and forty knees. J Bone Joint Surg Am 2002; 84A: 759–762.

    Google Scholar 

  129. Chiu FY, Lin CF, Chen CM, Lo WH, Chaung TY: Cefuroxime-impregnated cement at primary total knee arthroplasty in diabetes mellitus: a prospective, randomised study. J Bone Joint Surg Br 2001; 83: 691–695.

    CAS  PubMed  Google Scholar 

  130. Lewis G, Bhattaram A: Influence of a pre-blended antibiotic (gentamicin sulfate powder) on various mechanical, thermal, and physical properties of three acrylic bone cements. J Biomater Appl 2006; 20: 377–408.

    CAS  PubMed  Google Scholar 

  131. Joseph TN, Chen AL, Di Cesare PE: Use of antibiotic-impregnated cement in total joint arthroplasty. J Am Acad Orthop Surg 2003; 11: 38–47.

    PubMed  Google Scholar 

  132. Chassaignac E: De l’osteo-myelite. Bull Mem Soc Chir 1852; 431–436.

  133. Lew DP, Waldvogel FA: Osteomyelitis. Lancet 2004; 364: 369–379.

    CAS  PubMed  Google Scholar 

  134. Cierny G, Mader JT, Penninck JJ: A clinical staging system for adult osteomyelitis. Contemp Orthop 1985; 10: 17–37.

    Google Scholar 

  135. Waldvogel FA, Medoff G, Swartz MN: Osteomyelitis: a review of clinical features, therapeutic considerations and unusual aspects. 3: osteomyelitis associated with vascular insufficiency. N Engl J Med 1970; 282: 316–322.

    CAS  PubMed  Google Scholar 

  136. Lew DP, Waldvogel FA: Osteomyelitis. N Engl J Med 1997; 336: 999–1007.

    CAS  PubMed  Google Scholar 

  137. Sax H, Lew D: Osteomyelitis. Curr Infect Dis Rep 1999; 1: 261–266.

    PubMed  Google Scholar 

  138. Waldvogel FA, Papageorgiou PS: Osteomyelitis: the past decade. N Engl J Med 1980; 303: 360–370.

    Article  CAS  PubMed  Google Scholar 

  139. Calhoun JH, Manring MM: Adult osteomyelitis. Infect Dis Clin North Am 2005; 19: 765–786.

    PubMed  Google Scholar 

  140. Gardam M, Lim S: Mycobacterial osteomyelitis and arthritis. Infect Dis Clin North Am 2005; 19: 819–830.

    PubMed  Google Scholar 

  141. Kohli R, Hadley S: Fungal arthritis and osteomyelitis. Infect Dis Clin North Am 2005; 19: 831–851.

    PubMed  Google Scholar 

  142. Mader JT, Shirtliff M, Calhoun JH: Staging and staging application in osteomyelitis. Clin Infect Dis 1997; 25: 1303–1309.

    CAS  PubMed  Google Scholar 

  143. Howard CB, Einhorn M, Dagan R, Yagupski P, Porat S: Fineneedle bone biopsy to diagnose osteomyelitis. J Bone Joint Surg Br 1994; 76: 311–314.

    CAS  PubMed  Google Scholar 

  144. Zuluaga AF, Galvis W, Saldarriaga JG, Agudelo M, Salazar BE, Vesga O: Etiologic diagnosis of chronic osteomyelitis: a prospective study. Arch Intern Med 2006; 166: 95–100.

    PubMed  Google Scholar 

  145. Senneville E, Melliez H, Beltrand E, Legout L, Valette M, Cazaubiel M, Cordonnier M, Caillaux M, Yazdanpanah Y, Mouton Y: Culture of percutaneous bone biopsy specimens for diagnosis of diabetic foot osteomyelitis: concordance with ulcer swab cultures. Clin Infect Dis 2006; 42: 57–62.

    PubMed  Google Scholar 

  146. White LM, Schweitzer ME, Deely DM, Gannon F: Study of osteomyelitis: utility of combined histologic and microbiologic evaluation of percutaneous biopsy samples. Radiology 1995; 197: 840–842.

    CAS  PubMed  Google Scholar 

  147. Modi SP, Eppes SC, Klein JD: Cat-scratch disease presenting as multifocal osteomyelitis with thoracic abscess. Pediatr Infect Dis J 2001; 20: 1006–1007.

    CAS  PubMed  Google Scholar 

  148. Morata P, Queipo-Ortuño MI, Reguera JM, Miralles F, Lopez-Gonzalez JJ, Colmenero JD: Diagnostic yield of a PCR assay in focal complications of brucellosis. J Clin Microbiol 2001; 39: 3743–3746.

    CAS  PubMed  Google Scholar 

  149. Weigl JA, Haas WH: Postoperative Mycobacterium avium osteomyelitis confirmed by polymerase chain reaction. Eur J Pediatr 2000; 159: 64–69.

    CAS  PubMed  Google Scholar 

  150. Kapoor A, Page S, Lavalley M, Gale DR, Felson DT: Magnetic resonance imaging for diagnosing foot osteomyelitis: a meta-analysis. Arch Intern Med 2007; 167: 125–132.

    PubMed  Google Scholar 

  151. Maurer AH, Chen DCP, Camargo EE: Utility of three-phase skeletal scintigraphy in suspected osteomyelitis: concise communication. J Nucl Med 1981; 22: 941–949.

    CAS  PubMed  Google Scholar 

  152. Schauwecker DS: The scintigraphic diagnosis of osteomyelitis. Am J Roentgenol 1992; 158: 9–18.

    CAS  Google Scholar 

  153. Deysine M, Rafkin H, Teicher I, Silver L, Robinson R, Manly J, Aufses AH Jr: Diagnosis of chronic and postoperative osteomyelitis with gallium 67 citrate scans. Am J Surg 1975; 129: 632–635.

    CAS  PubMed  Google Scholar 

  154. Santiago Restrepo C, Gimenez CR, McCarthy K: Imaging of osteomyelitis and musculoskeletal soft tissue infections: current concepts. Rheum Dis Clin North Am 2003; 29: 89–109.

    Google Scholar 

  155. Pakos EE, Koumoulis HD, Fotopoulos AD, Ioannidis JP: Osteomyelitis: antigranulocyte scintigraphy with 99mTC radiolabeled monoclonal antibodies for diagnosis-meta-analysis. Radiology 2007; 245: 732–741.

    PubMed  Google Scholar 

  156. Termaat MF, Raijmakers PG, Scholten HJ, Bakker FC, Patka P, Haarman HJ: The accuracy of diagnostic imaging for the assessment of chronic osteomyelitis: a systematic review and meta-analysis. J Bone Joint Surg Am 2005; 87: 2464–2471.

    CAS  PubMed  Google Scholar 

  157. Norden CW, Fierer J, Bryant RE: Chronic staphylococcal osteomyelitis: treatment with regimens containing rifampin. Rev Infect Dis 1983; 5(Suppl 3): S495–S501.

    PubMed  Google Scholar 

  158. Norden CW, Bryant R, Palmer D, Montgomerie JZ, Wheat J: Chronic osteomyelitis caused by Staphylococcus aureus: controlled clinical trial of nafcillin therapy and nafcillin-rifampin therapy. South Med J 1986; 79: 947–951.

    CAS  PubMed  Google Scholar 

  159. Leder K, Turnidge JD, Korman TM, Grayson ML: The clinical efficacy of continuous-infusion flucloxacillin in serious staphylococcal sepsis. J Antimicrob Chemother 1999; 43: 113–118.

    CAS  PubMed  Google Scholar 

  160. Bell SM: Oral penicillins in the treatment of chronic staphylococcal osteomyelitis. Lancet 1968; 2: 295–297.

    CAS  PubMed  Google Scholar 

  161. Hodgkin UG: Antibiotics in the treatment of chronic staphylococcal osteomyelitis. South Med J 1975; 68: 817–822.

    Google Scholar 

  162. Bryson YJ, Connor JD, LeClerc M, Giammona ST: High-dose oral dicloxacillin treatment of acute staphylococcal osteomyelitis in children. J Pediatr 1979; 94: 673–675.

    CAS  PubMed  Google Scholar 

  163. Cole WG, Dalziel RE, Leitz S: Treatment of acute osteomyelitis in childhood. J Bone Joint Surg 1982; 64: 218–223.

    CAS  Google Scholar 

  164. Hubbard MJS, Ndawula AL: A controlled trial of cloxacillin and tetracycline in chronic staphylococcal osteomyelitis in Ugandan children. East Afr Med J 1973; 50: 480–485.

    CAS  PubMed  Google Scholar 

  165. Hedstrom SA: Treatment of chronic staphylococcal osteomyelitis with cloxacillin and dicloxacillin: a comparative study in 12 patients. Scand J Infect Dis 1975; 5: 55–57.

    Google Scholar 

  166. Lazzarini L, Lipsky BA, Mader JT: Antibiotic treatment of osteomyelitis: what have we learned from 30 years of clinical trials?. Int J Infect Dis 2005; 9: 127–138.

    CAS  PubMed  Google Scholar 

  167. Darley ES, MacGowan AP: Antibiotic treatment of gram-positive bone and joint infections. J Antimicrob Chemother 2004; 53: 928–935.

    CAS  PubMed  Google Scholar 

  168. Dornbusch K, Carlström A, Hugo H, Lidström A: Antibacterial activity of clindamycin and lincomycin in human bone. J Antimicrob Chemother 1977; 3: 153–160.

    CAS  PubMed  Google Scholar 

  169. Kaplan SL, Mason EO Jr, Feigin RD: Clindamycin versus nafcillin or methicillin in the treatment of Staphylococcus aureus osteomyelitis in children. South Med J 1982; 75: 138–142.

    CAS  PubMed  Google Scholar 

  170. Rodriguez W, Ross S, Khan W, McKay D, Moskowitz P: Clindamycin in the treatment of osteomyelitis in children: a report of 29 cases. Am J Dis Child 1977; 131: 1088–1093.

    CAS  PubMed  Google Scholar 

  171. Desplaces N, Acar JF: New quinolones in the treatment of joint and bone infections. Rev Infect Dis 1988; 10(Suppl 1): S179–S183.

    PubMed  Google Scholar 

  172. Rissing JP: Antimicrobial therapy for chronic osteomyelitis in adults: role of the quinolones. Clin Infect Dis 1997; 25: 1327–1333.

    CAS  PubMed  Google Scholar 

  173. Gentry LO, Rodriguez GG: Oral ciprofloxacin compared with parenteral antibiotics in the treatment of osteomyelitis. Antimicrob Agents Chemother 1990; 34: 40–43.

    CAS  PubMed  Google Scholar 

  174. Mader JT, Cantrell JS, Calhoun J: Oral ciprofloxacin compared with standard parenteral antibiotic therapy for chronic osteomyelitis in adults. J Bone Joint Surg Am 1990; 72: 104–110.

    CAS  PubMed  Google Scholar 

  175. Gentry LO, Rodriguez-Gomez G: Ofloxacin versus parenteral therapy for chronic osteomyelitis. Antimicrob Agents Chemother 1991; 35: 538–541.

    CAS  PubMed  Google Scholar 

  176. Greenberg RN, Newman MT, Shariaty S, Pectol RW: Ciprofloxacin, lomefloxacin, or levofloxacin as treatment for chronic osteomyelitis. Antimicrob Agents Chemother 2000; 44: 164–166.

    CAS  PubMed  Google Scholar 

  177. Metallidis S, Topsis D, Nikolaidis J, Alexiadou E, Lazaraki G, Grovaris L, Theodoridou A, Nikolaidis P: Penetration of moxifloxacin and levofloxacin into cancellous and cortical bone in patients undergoing total hip arthroplasty. J Chemother 2007; 19: 682–687.

    CAS  PubMed  Google Scholar 

  178. Malincarne L, Ghebregzabher M, Moretti MV, Egidi AM, Canovari B, Tavolieri G, Francisci D, Cerulli G, Baldelli F: Penetration of moxifloxacin into bone in patients undergoing total kneearthroplasty. J Antimicrob Chemother 2006; 57: 950–954.

    CAS  PubMed  Google Scholar 

  179. Coombs RR: Fusidic acid in staphylococcal bone and joint infection. J Antimicrob Chemother 1990; 25(Suppl B): 53–60.

    PubMed  Google Scholar 

  180. Yourassowsky E, van der Linden MP, Lismont MJ, Crokaert F: Combination of minocycline and rifampicin against methicillinand gentamicin-resistant Staphylococcus aureus. J Clin Pathol 1981; 34: 559–563.

    CAS  PubMed  Google Scholar 

  181. Clumeck N, Marcelis L, Amiri-Lamraski MH, Gordts B: Treatment of severe staphylococcal infections with a rifampicin-minocycline association. J Antimicrob Chemother 1984; 13(Suppl C): 17–22.

    PubMed  Google Scholar 

  182. Sheftel TG, Mader JT, Pennick JJ, Cierny G III: Methicillin-resistant Staphylococcus aureus osteomyelitis. Clin Orthop Relat Res 1985; 198: 231–239.

    PubMed  Google Scholar 

  183. Fitzpatrick DJ, Cafferkey MT, Toner M, Beattie T, Keane CT: Osteomyelitis with methicillin-resistant Staphylococcus aureus. J Hosp Infect 1986; 8: 24–30.

    CAS  PubMed  Google Scholar 

  184. de Lalla F, Santoro D, Rinaldi E, Suter F, Cruciani M, Guaglianone MH, Rizzardini G, Pellegata G: Teicoplanin in the treatment of infections by staphylococci, Clostridium difficile and other Gram-positive bacteria. J Antimicrob Chemother 1989; 23: 131–142.

    PubMed  Google Scholar 

  185. Marone P, Concia E, Andreoni M, Suter F, Cruciani M: Treatment of bone and soft tissue infections with teicoplanin. J Antimicrob Chemother 1990; 25: 435–439.

    CAS  PubMed  Google Scholar 

  186. Weinberg WG: Safety and efficacy of teicoplanin for bone and joint infections: results of a community-based trial. South Med J 1993; 86: 891–897.

    CAS  PubMed  Google Scholar 

  187. LeFrock J, Ristuccia A: Teicoplanin in the treatment of bone and joint infections: an open study. J Infect Chemother 1999; 5: 32–39.

    CAS  PubMed  Google Scholar 

  188. Graninger W, Wenisch C, Wiesinger E, Menschik M, Karimi J, Presterl E: Experience with outpatient intravenous teicoplanin therapy for chronicosteomyelitis. Eur J Clin Microbiol Infect Dis 1995; 14: 643–647.

    CAS  PubMed  Google Scholar 

  189. Grüneberg RN: Anti-Gram-positive agents: what we have and what we would like. Drugs 1997; 54(Suppl 6): 29–38.

    PubMed  Google Scholar 

  190. Summers M, Misenhimer GR, Antony SJ: Vancomycin-resistant Enterococcus faecium osteomyelitis: successful treatment with quinupristin-dalfopristin. South Med J 2001; 94: 353–355.

    CAS  PubMed  Google Scholar 

  191. Rana B, Butcher I, Grigoris P, Murnaghan C, Seaton RA, Tobin CM: Linezolid penetration into osteo-articular tissues. J Antimicrob Chemother 2002; 50: 747–750.

    CAS  PubMed  Google Scholar 

  192. Aneziokoro CO, Cannon JP, Pachucki CT, Lentino JR: The effectiveness and safety of oral linezolid for the primary and secondary treatment of osteomyelitis. J Chemother 2005; 17: 643–650.

    CAS  PubMed  Google Scholar 

  193. Senneville E, Legout L, Valette M, Yazdanpanah Y, Giraud F, Beltrand E, Obert G, Dubreuil L, Migaud H, Mouton Y: Risk factors for anaemia in patients on prolonged linezolid therapy for chronic osteomyelitis: a case-control study. J Antimicrob Chemother 2004; 54: 798–802.

    CAS  PubMed  Google Scholar 

  194. Senneville E, Legout L, Valette M, Yazdanpanah Y, Beltrand E, Caillaux M, Migaud H, Mouton Y: Effectiveness and tolerability of prolonged linezolid treatment for chronic osteomyelitis: a retrospective study. Clin Ther 2006; 28: 1155–1163.

    CAS  PubMed  Google Scholar 

  195. Howden BP, Ward PB, Charles PG, Korman TM, Fuller A, du Cros P, Grabsch EA, Roberts SA, Robson J, Read K, Bak N, Hurley J, Johnson PD, Morris AJ, Mayall BC, Grayson ML: Treatment outcomes for serious infections caused by methicillin-resistant Staphylococcus aureus with reduced vancomycin susceptibility. Clin Infect Dis 2004; 38: 521–528.

    CAS  PubMed  Google Scholar 

  196. Rao N, Ziran BH, Hall RA, Santa ER: Successful treatment of chronic bone and joint infections with oral linezolid. Clin Orthop Relat Res 2004; 427: 67–71.

    PubMed  Google Scholar 

  197. Rayner CR, Baddour LM, Birmingham MC, Norden C, Meagher AK, Schentag JJ: Linezolid in the treatment of osteomyelitis: results of compassionate use experience. Infection 2004; 32: 8–14.

    CAS  PubMed  Google Scholar 

  198. Mader JT, Adams K: Comparative evaluation of daptomycin (LY146032) and vancomycin in the treatment of experimental methicillin-resistant Staphylococcus aureus osteomyelitis in rabbits. Antimicrob Agents Chemother 1989; 33: 689–692.

    CAS  PubMed  Google Scholar 

  199. Lamp KC, Friedrich LV, Mendez-Vigo L, Russo R: Clinical experience with daptomycin for the treatment of patients with osteomyelitis. Am J Med 2007; 120(10 Suppl 1): S13–S20.

    CAS  PubMed  Google Scholar 

  200. Holtom PD, Zalavras CG, Lamp KC, Park N, Friedrich LV: Clinical experience with daptomycin treatment of foot or ankle osteomyelitis: a preliminary study. Clin Orthop Relat Res 2007; 461: 35–39.

    PubMed  Google Scholar 

  201. Pavoni GL, Falcone M, Baiocchi P, Tarasi A, Cassone M, Serra P, Venditti M: Conservative medical therapy of infections following osteosynthesis: a retrospective analysis of a six year experience. J Chemother 2002; 14: 378–383.

    CAS  PubMed  Google Scholar 

  202. Parsons B, Strauss E: Surgical management of chronic osteomyelitis. Am J Surg 2004; 188(1A Suppl): 57–66.

    PubMed  Google Scholar 

  203. Leach RM, Rees PJ, Wilmshurst P: Hyperbaric oxygen therapy. Br Med J 1998; 317: 1140–1143.

    CAS  Google Scholar 

  204. Davis JC, Heckman JD, DeLee JC, Buckwold FJ: Chronic nonhematogenous osteomyelitis treated with adjuvant hyperbaric oxygen. J Bone Joint Surg Am 1986; 68: 1210–1217.

    CAS  PubMed  Google Scholar 

  205. Berendt AR: Counterpoint: hyperbaric oxygen for diabetic foot wounds is not effective. Clin Infect Dis 2006; 15: 193–198.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Dipartimento Malattie Infettive, Seconda Università di Napoli, Naples, Italy

    S. Esposito

  2. U.O.C. Malattie Infettive, A.O.R.N. “San Giuseppe Moscati”, Avellino, Italy

    S. Leone

  3. Clinica Malattie Infettive, A.O.U. San Martino, Genova, Italy

    M. Bassetti

  4. S.C.D.O. Prevenzione Rischio Infettivo, A.S.O. “Maggiore della Carità”, Novara, Italy

    S. Borrè

  5. S.O.D. Malattie Infettive, A.O.U Careggi, Florence, Italy

    F. Leoncini

  6. UOC Centro per il Trattamento delle Complicanze Ortopediche Settiche (COS), Istituto Ortopedico G. Pini, Milan, Italy

    E. Meani

  7. Dipartimento di Malattie Infettive e Tropicali, Università “La Sapienza”, Rome, Italy

    M. Venditti

  8. S.C. Malattie Infettive, A.S. Firenze, Rome, Italy

    F. Mazzotta

Authors
  1. S. Esposito
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. Leone
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. Bassetti
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. S. Borrè
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. F. Leoncini
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. E. Meani
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. M. Venditti
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. F. Mazzotta
    View author publications

    You can also search for this author in PubMed Google Scholar

Consortia

Bone Joint Infections Committee for the Italian Society of Infectious Tropical Diseases (SIMIT)

Corresponding author

Correspondence to S. Esposito.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Esposito, S., Leone, S., Bassetti, M. et al. Italian Guidelines for the Diagnosis and Infectious Disease Management of Osteomyelitis and Prosthetic Joint Infections in Adults. Infection 37, 478–496 (2009). https://doi.org/10.1007/s15010-009-8269-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15010-009-8269-2

Keywords

Search

Navigation